Summary of project PR001693

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001693. The data can be accessed directly via it's Project DOI: 10.21228/M8VT66 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR001693
Project DOI:doi: 10.21228/M8VT66
Project Title:Role of AICARP, an endogenous AMPK activator, in improved endurance capacity in diabetic mice during SGLT2 inhibition.
Project Type:Wide targeted metabolomics & lipidomics
Project Summary:Diabetes is often associated with increased risk of deleterious muscle mass and function or sarcopenia, thus leading to physical inactivity and metabolic disorders. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are an oral antidiabetic drug that promotes urinary excretion of glucose in the renal proximal tubules. However, how SGLT2 inhibition affects the skeletal muscle function in patients with diabetes remains elusive. Here, we examined the differential effect of CANA on the oxidative soleus and glycolytic EDL muscles from genetically obese diabetic db/db mice.
Institute:Medical Institute of Bioregulation, Kyushu University
Department:Metabolomics
Laboratory:Bamba lab.
Last Name:Takahashi
First Name:Masatomo
Address:Maidashi 3-1-1, Higashi-ku, Fukuoka, Fukuoka, 8128582, Japan
Email:m-takahashi@bioreg.kyushu-u.ac.jp
Phone:0926426171
Publications:https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.13350

Summary of all studies in project PR001693

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST002729 Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. Mus musculus Medical Institute of Bioregulation, Kyushu University MS 2023-11-09 1 36 Uploaded data (68.8G)*
  logo